Be a part of us for an insightful dialog with Jennifer Harakal, Head of Regulatory Affairs at Cover Life Sciences, as we unpack the evolving intersection of social media and healthcare choices. Uncover how pharmaceutical firms can navigate regulatory challenges whereas meaningfully partaking with customers in digital areas. Jennifer shares knowledgeable methods for accountable advertising, working with influencers, and creating instructional content material that bridges the hole between sufferers and healthcare suppliers. A must-listen for pharma entrepreneurs trying to construct belief and compliance in at the moment’s social media panorama.
Novartis grabs kidney drug developer Regulus in $1.7bn deal
Novartis has reached an settlement to purchase Regulus Therapeutics and its experimental remedy for autosomal dominant polycystic kidney illness (ADPKD)...
